| Sep 9 |
Why you Should Buy the 200-day Dip in ARM, MSTR, VKTX
|
| Sep 9 |
Viking Therapeutics, Inc. (VKTX) Laps the Stock Market: Here's Why
|
| Sep 7 |
Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?
|
| Sep 5 |
Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year
|
| Sep 4 |
Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
| Sep 4 |
Several Factors Negatively Impacted Viking Therapeutics (VKTX) in Q2
|
| Sep 3 |
Viking Surges 342% in the Past Year: How Should You Play the Stock?
|
| Aug 30 |
Viking Therapeutics: GLP-1/GIP Receptor Agonist And Its Competitive Landscape
|
| Aug 29 |
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
|
| Aug 29 |
Viking Therapeutics (VKTX) Fell Amid Rising Competition
|
